Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,101,577 papers from all fields of science
Search
Sign In
Create Free Account
6059-S
Known as:
6059 S
, S-6059
, 6059S
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Disodium Latamoxef
Moxalactam
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The effect of mixing organic biological waste materials and high-N crop residues on the short-time N2O emission from horticultural soil in model experiments
B. Chaves
,
S. Neve
,
Maria Carmen Lillo Cabrera
,
P. Boeckx
,
O. Cleemput
,
G. Hofman
Biology and Fertility of Soils
2005
Corpus ID: 8862703
Manipulating the N release from high-N crop residues by simultaneous mixing of these residues with organic biological waste (OBW…
Expand
1981
1981
[Basic and clinical examinations of 6059-S in pediatrics (author's transl)].
N. Yamashita
,
K. Sunakawa
,
+7 authors
M. Hirose
The Japanese Journal of Antibiotics
1981
Corpus ID: 19276593
1. MIC of 6059-S against 92 strains of clinically isolated bacteria were measured. The compound was active against most of Gram…
Expand
1981
1981
[Experimental and clinical studies on 6059-S (author's transl)].
Y. Toyonaga
,
M. Sugita
,
Y. Kurosu
,
K. Kumagai
,
M. Hori
,
T. Takahashi
The Japanese Journal of Antibiotics
1981
Corpus ID: 23804965
Experimental and clinical studies in the pediatric field on 6059-S, a newly synthesized broad spectrum parenteral antibiotics…
Expand
1981
1981
Effect of 6059-S, a novel oxacephem, on cross-linking reaction of peptidoglycan biosynthesis in Escherichia coli, Pseudomonas aeruginosa and Serratia marcescens
N. Takata
,
M. Ogawa
,
G. Kōsaki
,
H. Suginaka
Archives of Microbiology
1981
Corpus ID: 7171531
The effect of 6059-S, a novel 1-oxacephem, on peptidoglycan synthesis was investigated using ether-treated cells of Escherichia…
Expand
1981
1981
[Laboratory and clinical studies on 6059-S in children (author's transl)].
N. Iwai
,
A. Sasaki
,
Y. Taneda
,
T. Osuga
,
K. Inokuma
The Japanese Journal of Antibiotics
1981
Corpus ID: 28262922
Laboratory and clinical studies were performed on 6059-S in the field of pediatrics, a new semi-synthetic 1-oxacephem antibiotic…
Expand
1981
1981
High-performance liquid chromatographic analysis of a new beta-lactam antibiotic, 6059-S (moxalactam).
R. Konaka
,
K. Kuruma
,
R. Nishimura
,
Y. Kimura
,
T. Yoshida
Journal of Chromatography A
1981
Corpus ID: 30750338
1981
1981
[Clinical results and pharmacokinetics of 6059-S in the field of pediatrics (author's transl)].
M. Takimoto
,
Y. Kusunoki
,
K. Chou
,
H. Yoshioka
,
N. Sanae
,
S. Maruyama
The Japanese Journal of Antibiotics
1981
Corpus ID: 9030244
6059-S, a new injectable oxacephem antibiotic, has been investigated to give following results. 1. Clinical results Twenty…
Expand
Highly Cited
1980
Highly Cited
1980
Moxalactam (6059-S), a Novel 1-Oxa-β-Lactam with an Expanded Antibacterial Spectrum: Laboratory Evaluation
Tadashi Yoshida
,
S. Matsuura
,
M. Mayama
,
Y. Kameda
,
S. Kuwahara
Antimicrobial Agents and Chemotherapy
1980
Corpus ID: 9950157
Moxalactam (6059-S) {7β-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7α-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]-methyl]-1-oxa-1…
Expand
1980
1980
Moxalactam (6059-S), a new 1-oxa-beta-lactam: binding affinity for penicillin-binding proteins of Escherichia coli K-12
Yoshihide Komatsu
,
H. Satoh
,
H. Itani
Antimicrobial Agents and Chemotherapy
1980
Corpus ID: 31121077
Moxalactam (6059-S) is a new beta-lactam derivative with a structure markedly different from those of penicillins or…
Expand
1980
1980
The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic.
C. Warren
,
B. A. King
,
K. Shannon
,
S. Eykyn
,
I. Phillips
Journal of Antimicrobial Chemotherapy
1980
Corpus ID: 31107884
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE